Summary:
In this study, researchers will evaluate an add-on investigational drug for major depressive disorder (MDD).
Qualified Participants Must:
• Be 18 to 65
•
Be diagnosed with depression
•
Be taking an antidepressant medication
•
Have an Inadequate response to at least one antidepressant medication including the current medication
Qualified Participants May Receive:
Qualified participants may receive study-related:
Investigational Drug
Psychiatric evaluations
Follow-up Visits
Compensation for time and travel